A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis

NCT02778399 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: Placebo
DRUG: OBE2109

Sponsor

ObsEva SA